New cataract device tested, but study halted early

NCT ID NCT05729477

Terminated Disease control Sponsor: Carl Zeiss Meditec, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compared a new device called miCOR, which uses low energy to break up cataracts, to standard cataract surgery. About 402 adults with cataracts were planned to take part. The study was terminated early, so we don't have full results on whether the new device is better or safer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: miCOR System device
What this could lead to: If successful, this could offer a safer, less energy-intensive way to remove cataracts during surgery.
What could go wrong: The study was terminated, so we have limited data. The device may not be better than standard methods, and any new device carries surgical risks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CATARACT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cataract

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CATARACT SURGERY

Contacts and locations

Locations

Argus Research at Cape Coral Eye Center

Cape Coral, Florida, 33904, United States
Mittleman Eye

West Palm Beach, Florida, 33409, United States
Penn State Health Eye Center

Hershey, Pennsylvania, 17033, United States
The eye Centers of Racine and Kenosh

Racine, Wisconsin, 53405, United States
Virginia Eye Consultants

Norfolk, Virginia, 23502, United States
Wolfe Eye Clinic

Hiawatha, Iowa, 52233, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.